CUTIXONE SB

Introduction

CUTIXONE SB is a prescription injectable antibiotic containing Ceftriaxone 1000 mg and Sulbactam 500 mg, a scientifically established combination indicated for the treatment of moderate to severe bacterial infections caused by susceptible microorganisms. The combination pairs the broad-spectrum antibacterial activity of Ceftriaxone, a third-generation cephalosporin, with Sulbactam, a β-lactamase inhibitor that enhances antibacterial efficacy against susceptible β-lactamase-producing bacteria.

CUTIXONE SB is widely used in hospital and healthcare settings for the management of serious infections involving the respiratory tract, urinary tract, abdomen, skin and soft tissues, bloodstream, and surgical sites. Its broad antimicrobial spectrum, excellent tissue penetration, and prolonged half-life make it an important option for the treatment of severe community-acquired and hospital-associated bacterial infections when clinically indicated.

When used appropriately and guided by antimicrobial stewardship principles, CUTIXONE SB helps eradicate susceptible bacteria, promotes clinical recovery, and reduces the risk of infection-related complications.

Uses of CUTIXONE SB

CUTIXONE SB is indicated for the treatment of bacterial infections caused by susceptible microorganisms.

It may be prescribed for:

1. Respiratory tract infections
2. Urinary tract infections (UTIs)
3. Skin and soft tissue infections (SSTIs)
4. Intra-abdominal infections
5. Surgical site infections (SSIs)
6. Bloodstream infections (bacteremia and septicemia)
7. Bone and joint infections
8. Gynecological infections
9. Meningitis caused by susceptible organisms
10. Other severe bacterial infections requiring parenteral antibiotic therapy

Note: CUTIXONE SB is effective only against bacterial infections and should not be used for viral illnesses such as the common cold or influenza.

Benefits of CUTIXONE SB

CUTIXONE SB combines a broad-spectrum cephalosporin antibiotic with a β-lactamase inhibitor to provide enhanced antibacterial coverage against susceptible pathogens.

Scientific benefits include:

1. Broad-spectrum activity against many clinically important Gram-positive and Gram-negative bacteria.
2. Sulbactam inhibits β-lactamase enzymes, helping protect Ceftriaxone from enzymatic degradation and restoring activity against susceptible β-lactamase-producing organisms.
3. Effective in the treatment of moderate to severe bacterial infections requiring injectable antibiotic therapy.
4. Excellent penetration into the lungs, urinary tract, abdominal cavity, skin, soft tissues, bones, joints, and cerebrospinal fluid during meningeal inflammation.
5. Long elimination half-life supports convenient dosing in many clinical situations.
6. Well-established clinical efficacy in hospital and community-acquired bacterial infections.
7. Supports evidence-based antimicrobial therapy when prescribed according to antimicrobial stewardship principles and local susceptibility patterns.

How CUTIXONE SB Works

CUTIXONE SB works through the complementary actions of Ceftriaxone and Sulbactam.

Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This disrupts the formation of the bacterial cell wall, leading to bacterial cell death.

Some bacteria produce β-lactamase enzymes, which can inactivate β-lactam antibiotics. Sulbactam irreversibly inhibits many of these β-lactamase enzymes, protecting Ceftriaxone from degradation and extending its activity against susceptible β-lactamase-producing organisms.

By combining these complementary mechanisms, CUTIXONE SB provides enhanced antibacterial activity against a broad range of susceptible pathogens, helping achieve effective infection control and improved clinical outcomes.

Dosage & Administration

CUTIXONE SB should be administered only by a qualified healthcare professional.

General Adult Dosage

1. The dosage should be individualized based on the type, severity, and site of infection, the causative organism, patient age, body weight, and renal or hepatic function.
2. CUTIXONE SB may be administered by intravenous (IV) or intramuscular (IM) injection, as directed by the treating physician.
3. Treatment duration depends on the patient's clinical response and the nature of the infection.
4. Whenever possible, therapy should be guided by bacterial culture and antimicrobial susceptibility testing.
5. The full prescribed course should be completed to ensure effective bacterial eradication and reduce the risk of antimicrobial resistance.

Possible Side Effects

Like all medicines, CUTIXONE SB may cause side effects, although many patients tolerate treatment well.

Commonly reported side effects include:

1. Pain, redness, or swelling at the injection site
2. Diarrhea
3. Nausea
4. Vomiting
5. Mild skin rash
6. Headache
7. Elevated liver enzyme levels
8. Temporary changes in blood cell counts

Patients should seek immediate medical attention if they experience severe allergic reactions, persistent or severe diarrhea, difficulty breathing, widespread skin reactions, or symptoms suggestive of severe infection-related complications.

Contraindications & Precautions

CUTIXONE SB should not be used in patients with:

1. Known hypersensitivity to Ceftriaxone, Sulbactam, cephalosporins, or any component of the formulation.
2. A history of severe immediate hypersensitivity reactions (e.g., anaphylaxis) to penicillins or other β-lactam antibiotics.
3. Hyperbilirubinemic neonates or premature neonates, where Ceftriaxone may displace bilirubin from albumin.
4. Neonates requiring intravenous calcium-containing solutions due to the risk of ceftriaxone-calcium precipitation.

Important Precautions

CUTIXONE SB should be used with caution in patients with:

1. Renal or hepatic impairment.
2. A history of antibiotic-associated colitis or significant gastrointestinal disease.
3. Gallbladder or biliary disorders, as Ceftriaxone may rarely cause biliary sludge or pseudolithiasis.
4. Bleeding disorders or vitamin K deficiency.
5. Elderly or immunocompromised patients.
6. Pregnancy or breastfeeding, only if considered clinically appropriate by the treating physician.

Patients should inform their healthcare provider about all prescription medicines, over-the-counter medicines, and herbal supplements before receiving CUTIXONE SB, as certain medicines may interact with cephalosporin antibiotics.

Regular clinical monitoring and appropriate microbiological evaluation are recommended during prolonged therapy to optimize treatment outcomes and support responsible antibiotic use.

Disclaimer

The information provided on this page is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. CUTIXONE SB is a prescription medicine and should be administered only under the supervision of a qualified healthcare professional. Patients should always follow their physician's advice regarding dosage, duration of treatment, and monitoring. Clinical decisions should be individualized based on the patient's medical condition, microbiological findings, and current evidence-based infectious disease treatment guidelines.